Comparison of Laser Photocoagulation with Intravitreal Bevacizumab (Avastin) in Treating the Patients of Diabetic Macular Edema
Abstract
Purpose: To compare the efficacy of laser photocoagulation with intravitreal Avastin for the treatment of postoperative decrease of vision in patients with diabetic macular edema. Material and methods: randomized, controlled, open label, parallel group study of 80 eyes of 80 patients, having diabetic macular edema. The primary end point was change in best corrected visual acuity at 3 months compared with that at baseline using Snellen’s visual acuity testing charts. Results: The mean changes in BCVA at 3 months compared with that at baseline were more improvement of visual acuity in group B (Bevacizumab group) as compared to group A (Argon laser photocoagulation group). Conclusions: Intravitreal Bevacizumab appears to be beneficial in treatment of diabetic macular edema as compared to argon laser photocoagulation three months after treatment.
Published
Issue
Section
License
OWNERSHIP OF COPYRIGHT
The copyright in this website and the material on this website (including without limitation the text, computer code, artwork, photographs, images, music, audio material, video material and audio-visual material on this website) is owned by OPHTHALMOLOGY PAKISTAN.
Â
COPYRIGHT LICENSE
OPHTHALMOLOGY PAKISTAN grants to you a worldwide non-exclusive royalty-free revocable license to:
a) view this website and the material on this website on a computer or mobile device via a web browser;
b) copy and store this website and the material on this website in your web browser cache memory; and
c) print pages from this website for your use.
d) OPHTHALMOLOGY PAKISTAN permits all published articles to be copied, redistributed, remixed, transmitted and the work be adapted provided the original work and source is appropriately cited.
OPHTHALMOLOGY PAKISTAN does not grant any other rights in relation to this website or the material on this website. In other words, all other rights are reserved.
For the avoidance of doubt, you must not adapt, edit, change, transform, publish, republish, distribute, redistribute, broadcast, rebroadcast or show or play in public this website or the material on this website (in any form or media) without appropriately and conspicuously citing the original work and source or OPHTHALMOLOGY PAKISTAN prior written permission.
Â
PERMISSIONS
You may request permission to use the copyright materials on this website by writing to chiefeditor@ophthalmologypakistan.com.
Â
ENFORCEMENT OF COPYRIGHT
OPHTHALMOLOGY PAKISTAN takes the protection of its copyright very seriously.
If OPHTHALMOLOGY PAKISTAN discovers that you have used its copyright materials in contravention of the license above, OPHTHALMOLOGY PAKISTAN may bring legal proceedings against you seeking monetary damages and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of OPHTHALMOLOGY PAKISTAN' copyright materials that contravenes or may contravene the license above, please report this by email to chiefeditor@ophthalmologypakistan.com.
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to chiefeditor@ophthalmologypakistan.com.
